Quality and Outcome Measurements of Urological Patients
- Conditions
- Urologic Diseases
- Registration Number
- NCT04763538
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Brief Summary
Prospectively, all available parameters of urologic patients treated at the study sites will be acquired and stored in multilayered databases. Upon a given samples size, neuronal networks will be trained to define clinical endpoints. Beside uro-oncological patients also patients with other urological diseases will be enrolled.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 2000
- All patients treated at the study sites, signed informed consent
- No consent to record medical history
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease specific primary endpoint 4-5 years Neuronal networks will be trained to define the respective endpoints for the diseases
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (2)
Roland Seiler
🇨🇭Biel, Switzerland
Department of Urology, Hospital Center Biel
🇨🇭Biel, Switzerland
Roland Seiler🇨🇭Biel, SwitzerlandRoland Seiler, Prof.Contact+41 32 324 24 24r_seiler@gmx.ch